It’s over, Olympic. Eli Lilly’s new daily pill has shown results comparable to injections—without the needles. Using a simple once-a-day pill, patients lost an average of 16 pounds and saw their blood sugar levels normalize.
Overnight, the company’s stock rose 14%, adding $100 billion to its value. The drug could be a game-changer for the 1+ billion people with obesity and diabetes—and a serious disruption to the $100B+ weight-loss drug market.
